Eikon Therapeutics buys global rights to several clinical-stage assets
In addition to the transactions, Eikon has concluded the initial portion of a Series C equity financing, securing…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
02 Jun 23
In addition to the transactions, Eikon has concluded the initial portion of a Series C equity financing, securing…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
01 Jun 23
Cobitolimod, a TLR9 agonist, is currently undergoing evaluation in the global phase III programme, known as CONCLUDE, as…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
29 May 23
Inpefa is an oral inhibitor of sodium-glucose cotransporter types 2 and 1 (SGLT2 and SGLT1), administered as a…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
25 May 23
With an extensive pipeline focused on DDR and strategic partnerships with global pharmaceutical companies, Artios has chosen ANGLE…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
24 May 23
Post-merger, the combined firm, which is expected to operate as TuHURA Biosciences and trade on Nasdaq Capital Market,…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
23 May 23
VectivBio’s lead investigational product is apraglutide, a next-generation, long-acting synthetic GLP-2 analog in phase 3, which is being…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
23 May 23
Switzerland-based Novartis will pay AVROBIO $87.5m in cash at closing as compensation for the sale and transfer of…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
22 May 23
According to the terms of the contract, Croda will purchase a licence from Amyris to market, distribute, and…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
12 May 23
Bentracimab is a novel, monoclonal antibody fragment that reverses the antiplatelet activity of ticagrelor, an antiplatelet medicine marketed…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
11 May 23
The transaction, which has been unanimously approved by the Board of Directors of both the companies, is expected…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates